What role for 15-deoxyspergualin in enhancing engraftment of unrelated, histoincompatible canine marrow grafts and preventing graft-versus-host disease?
Raff
R F
RF
Fred Hutchinson Cancer Research Center, University of Washington School of Medicine, Seattle 98104.
Storb
R
R
Graham
T
T
Deeg
H J
HJ
Pepe
M
M
Schaffer
R
R
Sale
G E
GE
Schuening
F
F
Appelbaum
F R
FR
D000818:Animals; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation / Q000276:immunology*; D004285:Dogs; D006085:Graft Survival / Q000187:drug effects* / Q000528:radiation effects; D006086:Graft vs Host Disease / Q000517:prevention & control*; D006146:Guanidines / Q000494:pharmacology* / Q000633:toxicity; D015234:HLA-A Antigens / Q000032:analysis; D015235:HLA-B Antigens / Q000032:analysis; D006648:Histocompatibility; D007166:Immunosuppressive Agents / Q000494:pharmacology* / Q000633:toxicity; D013997:Time Factors; D014916:Whole-Body Irradiation
D006146:Guanidines; D015234:HLA-A Antigens; D015235:HLA-B Antigens; D007166:Immunosuppressive Agents; C037258:gusperimus